No profile data available.
Nuwellis, Inc. (NUWE) is a healthcare company in the heart treatment equipment industry, based in Eden Prairie, United States, with about 38 full-time employees.
It reported revenue of $8.74 million for fiscal year 2024, down 1.4% from fiscal year 2023, and net income of -$10.62 million. In Q3 2025 (the quarter ended September 30, 2025) revenue was $2.22 million, down 6.3% from a year before. Its market capitalization was $2.51 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of October 9, 2026.
, a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients.
Nuwellis reported $8.74 million in revenue for fiscal year 2024, down 1.4% from $8.86 million in fiscal year 2023. In Q3 2025 revenue was $2.22 million.
$2.51 million as of October 9, 2026.
Listed companies of a similar size in the same industry (heart treatment equipment) include HeartSciences Inc. (HSCS), Cardiac Biotech Solutions Inc. (CBSC), Adagio Medical Holdings, Inc. (ADGM), Biotricity, Inc. (BTCY).